Rosiglitazone

Brand name: Avandia

C

Score C — Probable Hepatotoxin

This drug is probably linked to idiosyncratic liver injury, but has been reported uncommonly and no characteristic signature has been identified.

Fewer than 12 cases without a significant case series.

Primary class Endocrine
Secondary class Diabetes
FDA approval 1999